Skip to content

A critical observation on the role of Breeze detoxification capsules in the role effect the coagulation function and the level of D-Dimmer in acute lung injury patients

A critical observation on the role of Breeze detoxification capsules in the role effect the coagulation function and the level of D-Dimmer in acute lung injury patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004695
Enrollment
Unknown
Registered
2014-05-07
Start date
2014-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute lung injury

Interventions

Research group:Breeze detoxification capsules plus Routine treatment
Control group:Routine treatment

Sponsors

Zhongshan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Timing: within 1-3 days the newly issued patients with acute lung injury due to viral or bacterial ; age between 16-75 years old; 2.Chest imaging: Patients of Bilateral pulmonary infiltrates or effusion; 3.Origin of edema: Respiratory failure not fully explained by cardiac failure or fluid overload need objective assessment (eg, echocardiography) to exclude hydrostatic edema if no risk factor present; 4.Oxygenation: PaO2/FiO2=300mmHg, or PEEP=5cmH2O.

Exclusion criteria

Exclusion criteria: 1. Reluctant to sign an informed consent form; 2. The cases in detection is not more than one week, or dropped out; 3. The patients with merge existing disease in the blood system or liver cirrhosis; 4. Cancer patients during chemotherapy; 5. The patients did not exceed half of a year after trauma or surgery; 6. Pregnant women, breastfeeding women and women who may be pregnant; 7. Patient with malignant cancer, HIV-infected patient; 8. Patients allergic to Breeze detoxification capsules; 9. Other situations that are inappropriate due to the researchers.

Design outcomes

Primary

MeasureTime frame
The coagulation function;D-Dimme;

Countries

China

Contacts

Public ContactTao Zhengang
taozhenggang@hotmail.com+86 13661685233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026